Rankings
▼
Calendar
BBIO Q2 2018 Earnings — BridgeBio Pharma, Inc. Revenue & Financial Results | Market Cap Arena
BBIO
BridgeBio Pharma, Inc.
$14B
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$35M
Net Income
-$27M
EPS (Diluted)
$-0.29
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$36M
Stock-Based Comp.
$1M
← FY 2018
All Quarters
Q3 2018 →
